Collegium Pharmaceutical Inc
Statements
Ratios
Valuation ratios (P/E, P/S, EV/EBITDA and the other multiples) are based on the closing price at the end of each period, not on the current price. Margins and returns are shown in percent, multiples without a unit, per-share figures in the reporting currency, net debt in millions.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||||||||||||||||||||||||||||||||||
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 3,101.6 | 41.5 | 26.5 | 23.2 | 9.1 | 6.9 | 8.9 | 16.1 | – | – | – | – | – | 104.5 | 26.7 | 17.2 | 13.0 | 17.5 | 16.6 | 22.4 | 31.9 | 23.6 | 29.2 | 17.7 | 24.5 | |
| 1,109.8 | 247.1 | 76.3 | 49.4 | 16.5 | 21.4 | 9.4 | 4.9 | 2.2 | 2.1 | 1.7 | 1.5 | 1.3 | 2.3 | 1.9 | 2.0 | 2.4 | 2.3 | 3.0 | 3.0 | 2.2 | 2.3 | 2.5 | 1.9 | 1.5 | 1.7 | 1.6 | 1.7 | 1.7 | 2.3 | 2.8 | 2.3 | 2.6 | 1.8 | 1.5 | 1.6 | 1.8 | 2.4 | 1.7 | 1.5 | |
| 6.1 | 3.1 | 2.6 | 3.9 | 3.2 | 5.8 | 9.3 | 9.5 | 6.9 | 6.3 | 5.8 | 5.1 | 4.6 | 7.9 | 4.1 | 3.9 | 4.2 | 3.8 | 5.7 | 3.9 | 2.8 | 3.1 | 3.5 | 3.0 | 2.8 | 4.0 | 4.6 | 4.6 | 5.3 | 6.6 | 7.2 | 6.0 | 6.6 | 5.0 | 4.2 | 5.0 | 5.0 | 6.1 | 4.2 | 3.8 | |
| 876.5 | 160.0 | 43.9 | 34.9 | 10.9 | 17.3 | 8.1 | 4.2 | 1.6 | 1.6 | 1.3 | 1.0 | 0.8 | 1.8 | 2.5 | 2.5 | 2.7 | 2.6 | 3.4 | 3.2 | 2.4 | 2.5 | 4.9 | 3.9 | 3.2 | 2.8 | 2.6 | 2.6 | 2.6 | 3.0 | 3.5 | 2.9 | 4.0 | 3.1 | 2.6 | 2.6 | 2.7 | 3.1 | 2.3 | 2.6 | |
| – | – | – | – | – | – | – | 55.3 | 7.5 | 4.8 | 5.5 | 7.1 | 12.8 | – | 49.4 | 15.2 | 9.5 | 6.7 | 7.7 | 7.4 | 5.8 | 8.1 | 23.4 | 16.6 | 11.4 | 7.5 | 6.6 | 5.9 | 5.3 | 5.6 | 5.6 | 4.7 | 6.9 | 5.7 | 5.2 | 5.4 | 5.1 | 4.0 | 3.1 | 3.6 | |
| – | – | – | – | – | – | – | 20.2 | 5.3 | 4.0 | 4.1 | 5.4 | 8.2 | 32.4 | 22.2 | 11.2 | 8.9 | 8.0 | 8.4 | 9.6 | 8.2 | 6.3 | 12.3 | 9.0 | 6.0 | 6.4 | 4.7 | 3.9 | 3.5 | 4.7 | 5.2 | 4.7 | 8.1 | 5.7 | 5.0 | 5.7 | 4.8 | 5.6 | 4.0 | 3.6 | |
| -13.5% | -17.9% | -29.6% | -23.0% | -25.0% | -11.2% | -4.0% | 5.0% | 18.8% | 25.0% | 24.4% | 18.5% | 12.2% | 3.1% | 4.5% | 9.0% | 11.3% | 12.5% | 11.9% | 10.5% | 12.2% | 15.9% | 8.2% | 11.2% | 16.8% | 15.7% | 21.3% | 25.5% | 28.3% | 21.3% | 19.2% | 21.2% | 12.4% | 17.7% | 20.0% | 17.4% | 21.0% | 17.8% | 24.9% | 27.9% | |
| Margins | ||||||||||||||||||||||||||||||||||||||||
| 92.9% | 87.6% | 85.0% | 84.4% | 91.1% | 90.9% | 49.7% | 42.6% | 37.1% | 40.9% | 41.0% | 40.8% | 41.1% | 34.7% | 39.1% | 46.0% | 52.2% | 58.0% | 61.2% | 60.8% | 60.2% | 54.4% | 52.6% | 46.5% | 43.8% | 45.2% | 45.4% | 48.4% | 51.5% | 57.5% | 60.0% | 61.9% | 62.4% | 59.8% | 57.7% | 56.7% | 57.2% | 59.3% | 60.7% | 60.0% | |
| -18,612.5% | -5,498.7% | -2,618.4% | -1,322.8% | -450.1% | -264.9% | -72.7% | -32.3% | -22.6% | -7.4% | -6.0% | -5.2% | -3.5% | -8.0% | -2.9% | 4.3% | 12.6% | 18.1% | 22.5% | 22.1% | 20.5% | 6.4% | -5.0% | -6.0% | -3.5% | 7.2% | 12.9% | 17.2% | 21.4% | 29.5% | 33.8% | 35.3% | 32.3% | 26.9% | 21.4% | 18.4% | 20.9% | 23.0% | 23.8% | 19.6% | |
| -18,662.3% | -5,504.1% | -2,616.6% | -1,319.4% | -447.8% | -262.9% | -78.2% | -39.1% | -30.1% | -14.0% | -10.4% | -7.4% | -3.9% | -7.7% | -4.2% | 0.1% | 5.7% | 8.6% | 13.1% | 32.7% | 31.8% | 25.8% | 15.7% | -11.2% | -11.8% | -5.4% | -5.6% | -2.1% | 1.6% | 8.5% | 16.5% | 17.3% | 14.8% | 11.0% | 6.6% | 5.1% | 7.7% | 8.1% | 9.4% | 5.9% | |
| -14,957.8% | -4,414.4% | -2,259.4% | -1,139.1% | -411.7% | -238.8% | -37.5% | 24.5% | 41.8% | 51.7% | 42.1% | 27.8% | 15.9% | 7.2% | 8.6% | 18.2% | 26.6% | 28.5% | 36.1% | 31.2% | 26.7% | 36.7% | 20.5% | 21.4% | 25.7% | 26.4% | 33.4% | 43.8% | 48.8% | 48.4% | 54.4% | 47.8% | 32.1% | 32.2% | 29.6% | 28.5% | 38.2% | 42.0% | 41.4% | 40.6% | |
| Returns | ||||||||||||||||||||||||||||||||||||||||
| -102.4% | -69.8% | -88.8% | -102.8% | -88.3% | -71.9% | -77.6% | -75.4% | -92.7% | -42.7% | -34.9% | -25.4% | -13.6% | -26.0% | -8.9% | 0.1% | 10.2% | 14.4% | 24.7% | 42.2% | 41.2% | 35.2% | 21.8% | -17.8% | -21.7% | -12.8% | -16.3% | -5.6% | 5.0% | 24.6% | 42.0% | 46.1% | 37.8% | 30.2% | 18.7% | 15.6% | 21.3% | 20.8% | 24.0% | 15.4% | |
| -77.1% | -58.1% | -72.7% | -78.9% | -69.3% | -55.2% | -10.1% | -9.3% | -10.1% | -13.4% | -10.3% | -7.2% | -3.8% | -7.4% | -2.0% | 0.0% | 2.7% | 4.2% | 6.5% | 15.0% | 14.0% | 10.3% | 3.4% | -2.8% | -3.6% | -2.1% | -2.4% | -0.9% | 0.8% | 4.2% | 8.4% | 9.5% | 5.4% | 4.2% | 2.7% | 2.3% | 3.6% | 3.8% | 4.5% | 2.2% | |
| Balance Sheet & Debt | ||||||||||||||||||||||||||||||||||||||||
| -95 | -149 | -126 | -108 | -105 | -117 | -115 | -111 | -128 | -135 | -122 | -136 | -141 | -158 | 171 | 132 | 102 | 84 | 103 | 71 | 69 | 64 | 663 | 625 | 591 | 528 | 530 | 472 | 453 | 429 | 396 | 381 | 830 | 783 | 743 | 707 | 640 | 560 | 536 | 964 | |
| – | – | – | – | – | – | – | -9.0 | -2.7 | -1.5 | -1.8 | -3.2 | -7.4 | – | 11.4 | 2.7 | 1.2 | 0.7 | 0.7 | 0.5 | 0.5 | 0.7 | 11.5 | 8.5 | 5.9 | 3.0 | 2.6 | 2.0 | 1.7 | 1.4 | 1.1 | 1.1 | 2.4 | 2.3 | 2.2 | 2.0 | 1.6 | 0.9 | 0.9 | 1.6 | |
| 75.3% | 83.3% | 81.8% | 76.7% | 78.5% | 76.8% | 13.0% | 12.3% | 10.9% | 31.4% | 29.3% | 28.5% | 27.7% | 28.5% | 22.2% | 24.1% | 26.8% | 28.9% | 26.3% | 35.5% | 33.8% | 29.3% | 15.7% | 15.9% | 16.4% | 16.6% | 14.8% | 16.5% | 15.2% | 17.1% | 19.9% | 20.6% | 14.3% | 13.8% | 14.4% | 14.6% | 17.1% | 18.2% | 18.9% | 14.6% | |
| -0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.3 | 0.2 | 0.1 | 0.1 | 0.1 | 0.2 | 0.1 | 2.0 | 1.8 | 1.6 | 1.4 | 1.7 | 1.1 | 1.0 | 1.2 | 3.9 | 3.8 | 3.7 | 3.6 | 4.4 | 3.8 | 4.0 | 3.4 | 2.8 | 2.6 | 3.7 | 3.7 | 3.6 | 3.5 | 2.9 | 2.7 | 2.6 | 3.5 | |
| Per Share | ||||||||||||||||||||||||||||||||||||||||
| -3.25 | -3.48 | -3.46 | -3.34 | -2.86 | -2.28 | -2.14 | -1.89 | -1.99 | -1.16 | -0.91 | -0.65 | -0.34 | -0.68 | -0.36 | 0.01 | 0.50 | 0.76 | 1.02 | 2.59 | 2.85 | 2.10 | 1.27 | -1.04 | -1.24 | -0.74 | -0.86 | -0.26 | 0.21 | 1.15 | 2.25 | 2.47 | 2.21 | 1.73 | 1.34 | 0.93 | 1.48 | 1.58 | 1.87 | 1.48 | |
| 0.02 | 0.06 | 0.13 | 0.25 | 0.64 | 0.87 | 2.74 | 4.84 | 6.60 | 8.30 | 8.74 | 8.78 | 8.84 | 8.83 | 8.52 | 8.60 | 8.78 | 8.75 | 7.80 | 7.90 | 8.98 | 8.11 | 8.10 | 9.22 | 10.46 | 13.81 | 15.30 | 12.53 | 13.00 | 13.56 | 13.68 | 14.28 | 14.92 | 15.74 | 20.23 | 18.09 | 19.20 | 19.66 | 19.88 | 24.90 | |
| 3.17 | 4.98 | 3.90 | 3.24 | 3.24 | 3.16 | 2.76 | 2.51 | 2.14 | 2.71 | 2.59 | 2.57 | 2.52 | 2.60 | 4.02 | 4.44 | 4.92 | 5.25 | 4.13 | 6.13 | 6.92 | 5.95 | 5.82 | 5.81 | 5.70 | 5.80 | 5.24 | 4.69 | 4.25 | 4.68 | 5.36 | 5.36 | 5.83 | 5.71 | 7.14 | 5.94 | 6.97 | 7.60 | 7.80 | 9.61 | |
| -2.60 | -2.79 | -2.99 | -2.88 | -2.63 | -2.07 | -1.03 | 1.18 | 2.76 | 4.29 | 3.68 | 2.44 | 1.41 | 0.64 | 0.73 | 1.57 | 2.34 | 2.50 | 2.82 | 2.47 | 2.40 | 2.98 | 1.66 | 1.98 | 2.69 | 3.65 | 5.11 | 5.49 | 6.34 | 6.56 | 7.44 | 6.83 | 4.79 | 5.07 | 5.99 | 5.16 | 7.34 | 8.25 | 8.23 | 10.11 | |
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.